HRT Financial’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
HRT Financial's FLGT Position: Q3 2026 in Review
HRT Financial reduced its Fulgent Genetics (FLGT) stake by 59% in Q3 2026, selling an estimated $2.71M and leaving 94,701 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.
HRT Financial first reported a position in FLGT in Q4 2022 and has held it in 12 quarters since. The position peaked at $4.71M in Q2 2026. 134 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- HRT Financial held 94,701 shares of Fulgent Genetics worth $2.08M as of Q3 2026.
- HRT Financial sold 134,743 Fulgent Genetics shares in Q3 2026, an estimated $2.71M.
- Fulgent Genetics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #1832 holding.
- HRT Financial first reported a position in Fulgent Genetics in Q4 2022 and has held it in 12 quarters since.
- HRT Financial's Fulgent Genetics position peaked at $4.71M in Q2 2026.
- 134 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.